Theravance Biopharma, Inc. Increase (Decrease) in Prepaid Expenses, Other
Theravance Biopharma, Inc. (TBPH) reported Increase (Decrease) in Prepaid Expenses, Other of -$414.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2026-08-11
- Theravance Biopharma, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2026-06-30 was $1.25M, a 17.36% decline year-over-year.
- Theravance Biopharma, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2026-03-31 was -$1.67M.
- Theravance Biopharma, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2025-12-31 was $814.00K.
- Theravance Biopharma, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2025-09-30 was $1.18M, a 15.30% decline year-over-year.
- Theravance Biopharma, Inc. increase (decrease) in prepaid expenses, other for fiscal 2025 was $3.36M.
- Theravance Biopharma, Inc. increase (decrease) in prepaid expenses, other for fiscal 2024 was -$7.40M, a 288.70% decline from fiscal 2023.
- Theravance Biopharma, Inc. increase (decrease) in prepaid expenses, other for fiscal 2023 was $3.92M, a 456.96% increase from fiscal 2022.
- Theravance Biopharma, Inc. increase (decrease) in prepaid expenses, other for fiscal 2022 was $704.00K.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 3 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 6 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 9 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 12 month | Increase (Decrease) in Prepaid Expenses, Other 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$414.00K 10-Q · filed 2026-08-11 | $400.00K derived: sum of 3 quarters · filed 2026-08-11 | $1.58M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | -$1.67M 10-Q · filed 2026-05-07 | -$852.00K derived: sum of 2 quarters · filed 2026-05-07 | $327.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.84M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $814.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $1.99M derived: sum of 2 quarters · filed 2026-03-23 | $3.51M derived: sum of 3 quarters · filed 2026-08-11 | $3.36M 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.69M derived: sum of 2 quarters · filed 2026-08-11 | $2.55M 10-Q · filed 2025-11-12 | -$927.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.37M 10-Q · filed 2026-08-11 | -$2.11M derived: sum of 3 quarters · filed 2026-08-11 | -$714.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | -$148.00K 10-Q · filed 2026-05-07 | -$3.62M derived: sum of 2 quarters · filed 2026-05-07 | -$2.23M derived: sum of 3 quarters · filed 2026-05-07 | -$3.51M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$3.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$2.08M derived: sum of 2 quarters · filed 2026-03-23 | -$3.37M derived: sum of 3 quarters · filed 2026-03-23 | -$7.40M 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $108.00K derived: sum of 2 quarters · filed 2025-11-12 | -$3.93M 10-Q · filed 2025-11-12 | -$1.32M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | -$1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$5.32M 10-Q · filed 2025-08-13 | -$2.71M derived: sum of 3 quarters · filed 2025-08-13 | -$1.49M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | -$4.03M 10-Q · filed 2025-05-12 | -$1.43M derived: sum of 2 quarters · filed 2025-05-12 | -$208.00K derived: sum of 3 quarters · filed 2025-05-12 | $1.29M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $3.83M derived: sum of 2 quarters · filed 2025-03-07 | $5.32M derived: sum of 3 quarters · filed 2025-03-07 | $3.92M 10-K · filed 2025-03-07 | ||||
| 2023-09-30 | $1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $2.72M derived: sum of 2 quarters · filed 2024-11-14 | $1.31M 10-Q · filed 2024-11-14 | $871.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $95.00K 10-Q · filed 2024-08-08 | -$349.00K derived: sum of 3 quarters · filed 2024-08-08 | $3.42M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$1.40M 10-Q · filed 2024-05-15 | -$1.84M derived: sum of 2 quarters · filed 2024-05-15 | $1.92M derived: sum of 3 quarters · filed 2024-05-15 | $1.74M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$444.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $3.32M derived: sum of 2 quarters · filed 2024-03-01 | $3.14M derived: sum of 3 quarters · filed 2024-03-01 | $704.00K 10-K · filed 2024-03-01 | ||||
| 2022-09-30 | $3.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $3.58M derived: sum of 2 quarters · filed 2023-11-09 | $1.15M 10-Q · filed 2023-11-09 | -$1.82M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$183.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$2.62M 10-Q · filed 2023-08-09 | -$5.58M derived: sum of 3 quarters · filed 2023-08-09 | -$7.48M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | -$2.44M 10-Q · filed 2023-05-10 | -$5.40M derived: sum of 2 quarters · filed 2023-05-10 | -$7.30M derived: sum of 3 quarters · filed 2023-05-10 | -$4.98M derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | -$2.97M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$4.86M derived: sum of 2 quarters · filed 2023-03-01 | -$2.54M derived: sum of 3 quarters · filed 2023-03-01 | -$2.87M 10-K · filed 2023-03-01 | ||||
| 2021-09-30 | -$1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $421.00K derived: sum of 2 quarters · filed 2022-11-09 | $99.00K 10-Q · filed 2022-11-09 | $152.00K derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.99M 10-Q · filed 2022-08-08 | $2.05M derived: sum of 3 quarters · filed 2023-03-01 | $4.06M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | -$322.00K 10-Q · filed 2022-05-06 | -$269.00K derived: sum of 2 quarters · filed 2023-03-01 | $1.74M derived: sum of 3 quarters · filed 2023-03-01 | $3.60M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $2.06M derived: sum of 2 quarters · filed 2023-03-01 | $3.92M derived: sum of 3 quarters · filed 2023-03-01 | $2.33M 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | $2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $3.87M derived: sum of 2 quarters · filed 2021-11-08 | $2.27M 10-Q · filed 2021-11-08 | $2.24M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | $1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $264.00K 10-Q · filed 2021-08-05 | $6.04M 10-Q · filed 2020-08-10 | $231.00K derived: sum of 3 quarters · filed 2022-02-28 | -$2.07M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | -$1.59M 10-Q · filed 2021-05-06 | -$1.63M derived: sum of 2 quarters · filed 2022-02-28 | -$3.93M derived: sum of 3 quarters · filed 2022-02-28 | -$3.65M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | -$33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$2.33M derived: sum of 2 quarters · filed 2022-02-28 | -$2.06M derived: sum of 3 quarters · filed 2022-02-28 | $73.00K 10-K · filed 2022-02-28 | $634.00K 10-K · filed 2020-02-27 | |||
| 2019-09-30 | -$2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$2.03M derived: sum of 2 quarters · filed 2020-11-09 | $106.00K 10-Q · filed 2020-11-09 | $681.00K 10-Q · filed 2019-11-08 | -$162.00K derived: sum of 4 quarters · filed 2021-02-26 | |||
| 2019-06-30 | $272.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $2.41M 10-Q · filed 2020-08-10 | $2.14M derived: sum of 3 quarters · filed 2021-02-26 | -$331.00K derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | $2.13M 10-Q · filed 2020-05-08 | $1.87M derived: sum of 2 quarters · filed 2021-02-26 | -$603.00K derived: sum of 3 quarters · filed 2021-02-26 | $782.00K derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | -$268.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$2.74M derived: sum of 2 quarters · filed 2021-02-26 | -$1.35M derived: sum of 3 quarters · filed 2021-02-26 | $225.00K 10-K · filed 2021-02-26 | $2.40M 10-K · filed 2019-02-28 | |||
| 2018-09-30 | -$2.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$1.08M derived: sum of 2 quarters · filed 2019-11-08 | $493.00K 10-Q · filed 2019-11-08 | $3.52M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $2.96M 10-Q · filed 2019-08-05 | $5.99M derived: sum of 3 quarters · filed 2020-02-27 | $2.38M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | $1.58M 10-Q · filed 2019-05-10 | $4.60M derived: sum of 2 quarters · filed 2020-02-27 | $998.00K derived: sum of 3 quarters · filed 2020-02-27 | $1.83M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$580.00K derived: sum of 2 quarters · filed 2020-02-27 | $252.00K derived: sum of 3 quarters · filed 2020-02-27 | $1.49M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | -$3.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$2.77M derived: sum of 2 quarters · filed 2018-11-08 | -$1.54M 10-Q · filed 2018-11-08 | $1.25M 10-Q · filed 2017-11-08 | -$3.45M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-06-30 | $832.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $2.07M 10-Q · filed 2018-08-02 | $1.86M 10-Q · filed 2017-08-09 | $155.00K derived: sum of 3 quarters · filed 2019-02-28 | $925.00K derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-03-31 | $1.24M 10-Q · filed 2018-05-09 | $1.21M 10-Q · filed 2017-05-10 | -$677.00K derived: sum of 2 quarters · filed 2019-02-28 | $93.00K derived: sum of 3 quarters · filed 2019-02-28 | -$6.52M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2016-12-31 | -$1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$1.14M derived: sum of 2 quarters · filed 2019-02-28 | -$7.76M derived: sum of 3 quarters · filed 2019-02-28 | -$2.71M 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | $770.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$5.85M derived: sum of 2 quarters · filed 2017-11-08 | -$796.00K 10-Q · filed 2017-11-08 | -$2.26M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-06-30 | -$6.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$1.57M 10-Q · filed 2017-08-09 | -$3.03M derived: sum of 3 quarters · filed 2018-02-28 | -$3.81M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-03-31 | $5.05M 10-Q · filed 2017-05-10 | $3.58M derived: sum of 2 quarters · filed 2018-02-28 | $2.80M derived: sum of 3 quarters · filed 2018-02-28 | $3.42M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2015-12-31 | -$1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | -$2.25M derived: sum of 2 quarters · filed 2018-02-28 | -$1.63M derived: sum of 3 quarters · filed 2018-02-28 | -$963.00K 10-K · filed 2018-02-28 | ||||
| 2015-09-30 | -$783.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$161.00K derived: sum of 2 quarters · filed 2016-11-09 | $503.00K 10-Q · filed 2016-11-09 | |||||
| 2015-06-30 | $622.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $1.29M 10-Q · filed 2016-08-09 | ||||||
| 2015-03-31 | $664.00K 10-Q · filed 2016-05-10 | |||||||
| 2014-12-31 | $2.88M 10-K · filed 2017-03-01 | |||||||
| 2013-12-31 | -$19.00K 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |